Athanasios Saratzis

Congratulations to Cambridge on their randomisation, this brings the study total to 327 participants! 🎉 Recruitment has been quieter in May with 6 participants recruited so far — please continue screening eligible patients. Thank you for your support! @LeicesterCTU @a_saratzis

1st newsletter for the @NIHRresearch RAVE RCT: lithotripsy vs. no lithotripsy in calcified #PAD lesions - take part now!

@GAEscobarMD @DanielCarradice @farkomd @jmills1955 The primary is a composite or amputation +/- re-intervention +/- mortality (all cause) & QoL data collected for everyone.

@a_saratzis @DanielCarradice @farkomd @jmills1955 If the primary endpoint is major amputation, it’s gonna take 30 years to get any data. Isolated common femoral artery intervention is rarely indicated for limb salvage… occasionally can be used for rest pain, and patches last forever. Prospective, long-term CFA study 1st

Should @farkomd and @jmills1955 have a debate of ENDO versus Open for management of isolated CFA disease in which @jmills1955 is allowed to pick all the rules of the debate (of which I’m fine with). Would you find it educational and entertaining?

@Tristan27856485 @naviyd @AmputationSuck @farkomd @jmills1955 Indeed! Get in touch to open your site now! 🇬🇧

@naviyd @AmputationSuck @farkomd @jmills1955 fundingawards.nihr.ac.uk/award/NIHR1674… already being done @a_saratzis

@DanielCarradice @farkomd @jmills1955 True. Open any NHS vascular hospital for recruitment now! Just DM and we'll set you up. We can't keep debating without actual RCT data 👇🏻

@farkomd @jmills1955 Maybe just open the NIHR RAF trial with @a_saratzis 😀

The final sprint is going strong, with 3 randomisations in the last week! Well done St George's @JooYoungChun2 and @LeicResearch This brings the target down to only 6 participants!! How quickly can we reach the finish?🏁 @a_saratzis @GSTTresearch @HullHospitals @MFT_Research

Seems like the momentum is picking back up again! 🚀 Huge congratulations to Newcastle on their 14th randomisation for EVOCC! 👏🥳🎉 @LeicesterCTU @a_saratzis @NewcastleHosps @NuTHResearch

Another randomisation 🎉which now brings us down to only 8⃣ participants left to recruit to KID. Amazing work St George's & @JooYoungChun2 and to all the sites that have got us this far!! @a_saratzis @LeicResearch @GSTTresearch @HullHospitals @MFT_Research

Why should everyone take part in vascular RCTs? 👇🏻

For all colleagues using endovascular means to treat #PAD. These two super important RCTs are about to open for recruitment. Get in touch if you want to take part. Multiple benefits for your unit & patients 🙏🏻👇🏻

🗞️The May KID Newsletter is now out🗞️ Take a look at the amazing progress from every site, and all the hard work that goes into this vital trial🌟 The end is in sight for recruitment! @a_saratzis @LeicResearch @GSTTresearch @HullHospitals @JooYoungChun2 @profkader @LeicsVascular

We had an amazing April beating last April's recruitment figures, with 11 randomisations!!🏆We are now in single digits, only 9 participants away from our final goal. Thank you for everyone involved👏@a_saratzis @LeicResearch @HullHospitals @MFT_Research @GSTTresearch @profkader

We're getting even closer to the final goal! Congrats to @MFT_Research for their randomisation. We're now only 9⃣ away from 175. How quickly can we get these last few participants? @a_saratzis @LeicResearch @GSTTresearch @HullHospitals @JooYoungChun2 @profkader @LeicsVascular

The best predictor of scientific impact isn't gender, seniority, methodology, or geography, it is the informal network of colleagues and mentors who provide guidance and feedback. We are often ignore the most important source of success. Informal support networks are the unsung heroes in science. Joining a great community of supportive and collaborative colleagues might therefore be one of the most important keys to success. This is based on a new paper analyzing the scientific impact of 86,000 scholars. The authors found that informal connections (ie the people who you thank in acknowledgement sections) are more important that your coauthors in predicting publication productivity and impact. pnas.org/doi/10.1073/pn…

Huge congratulations to North West London on their 12th randomisation for EVOCC this afternoon! 🥳🎉 @LeicesterCTU @a_saratzis

Congratulations to @HullHospitals and @GSTTresearch for their recruitment this week, with their randomisations we are now only 1⃣0⃣ participants away from our goal!! We're so close to the end now, let's keep going @a_saratzis @LeicResearch @MFT_Research @JooYoungChun2 @profkader

April's Beat your Best Challenge is coming towards the end, but theres still time to reach your target and win a Golden Mug 🌟 Check out your progress so far! @a_saratzis @LeicResearch @GSTTresearch @HullHospitals @MFT_Research @JooYoungChun2 @profkader

We're only 11 participants away from our final target!! Amazing work from every single person involved in the study 👏 Which site will be the one to get us to single digits? @a_saratzis @HullHospitals @LeicResearch @GSTTresearch @MFT_Research @JooYoungChun2 @profkader

Vascular people in 🇬🇧 who are recruiting into the @NIHRresearch KID trial...this is it. 10 weeks left. One patient per site this week 🤔💪🏻😊...there's now way we can't do this!

Week 3 of Beat Your Best Challenge Round 2 is now complete! Check out the amazing progress so far. Keep up the good work to reach your goal 🌟 @LeicResearch @GSTTresearch @HullHospitals @MFT_Research @a_saratzis @JooYoungChun2 @profkader